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BY-NC-ND license (http://creativecomBackground/Purpose: Some of recurrent aphthous stomatitis (RAS) patients had concomitant
atrophic glossitis (AG). This study assessed whether RAS patients with AG (AGþ/RAS patients)
or without AG (AG/RAS patients) had anemia and hematinic deficiencies and to evaluate
whether RAS combined with AG or RAS itself was a significant factor causing anemia and hema-
tinic deficiencies in AGþ/RAS or AG/RAS patients, respectively.
Methods: The mean corpuscular volume (MCV) and mean blood hemoglobin (Hb), iron, vitamin
B12, and folic acid levels were measured and compared between any two of three groups of
160 AGþ/RAS patients, 195 AG-/RAS patients, and 355 healthy control subjects.
Results: Both AGþ/RAS and AG/RAS patients had significantly lower mean Hb, iron, and
vitamin B12 levels as well as significantly greater frequencies of Hb, iron, vitamin B12, and fo-
lic acid deficiencies than healthy control subjects. Moreover, AGþ/RAS patients had signifi-
cantly lower mean Hb and serum iron level (for women only) and significantly greater
frequencies of Hb and iron deficiencies than AG/RAS patients. Of 69 anemia AGþ/RAS pa-
tients, 30 (43.5%) had normocytic anemia and 23 (33.3%) had iron deficiency anemia. Of 38
anemia AG/RAS patients, 26 (68.4%) had normocytic anemia and 5 (13.2%) had iron deficiency
anemia.
Conclusion: We conclude that some of AGþ/RAS or AG/RAS patients do have anemia and he-
matinic deficiencies and AGþ/RAS patients do have severer anemia statuses and ironave no conflicts of interest relevant to this article.
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role in causing anemia and hematinic deficiencies in AGþ/RAS or AG/RAS patients, respec-
tively.
Copyright ª 2016, Formosan Medical Association. Published by Elsevier Taiwan LLC. This is an
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nc-nd/4.0/).Introduction
Recurrent aphthous stomatitis (RAS) is a common oral
mucosal disease characterized by recurrent and painful
ulcerations on the nonkeratinized oral mucosae such as
labial, buccal, alveolar, and ventral tongue mucosae. The
prevalence of RAS ranges from 5% to 20% depending on the
population evaluated.1 In Taiwan, the prevalence of RAS is
10.5% in the general population.2
Although several etiological factors have been proposed,
the exact causes of RAS are still not very clear.3 The results of
previous studies on tissue infiltratedmononuclear cells favor
the role of cell-mediated cytotoxicity in the immunopatho-
genesis of RAS.4 In addition to immune dysregulation, mul-
tiple nutritional deficiencies including deficiencies of
vitamins B1, B2, B6, and B12, folate, iron, and ferritin are
considered to be the possible etiologies of RAS.4 Our previous
studies showed that 57 (20.9%), 55 (20.1%), 13 (4.8%) and 7
(2.6%) of 273 RAS patients as well as 39 (22.2%), 47 (26.7%),
13 (7.4%) and 3 (1.7%) of 176 atrophic glossitis (AG) patients
have deficiencies of Hb, iron, vitamin B12, and folic acid,
respectively.4,5 Our clinical experience revealed that a
portion of RAS patients may have concomitant AG. Thus, it
was interesting to knowwhether RAS patients with AG (AGþ/
RAS patients) had severer anemia status and hematinic de-
ficiencies than RAS patients without AG (AG/RAS patients).
In our oral mucosal disease clinic, patients with AG,
burning mouth syndrome (BMS), oral lichen planus (OLP),
RAS, oral submucous fibrosis (OSF), and other oral mucosal
diseases are frequently encountered.4e23 For AG, BMS, OLP,
RAS and OSF patients, complete blood count, serum iron,
vitamin B12, folic acid, homocysteine, and anti-gastric
parietal cell antibody (GPCA) levels are frequently exam-
ined to assess whether these patients have anemia, he-
matinic deficiencies, and serum GPCA positivity.4e20 In this
study, we collected 355 RAS patients including 160 AGþ/
RAS and 195 AG/RAS patients. Their complete blood
counts as well as serum iron, vitamin B12, folic acid, ho-
mocysteine and GPCA levels were examined and compared
with the corresponding data of 355 age- and sex-matched
healthy control subjects. The purposes of this study were
to study the anemia statuses and hematinic deficiencies in
these 160 AGþ/RAS and 195 AG/RAS patients, to assess
whether AGþ/RAS patients had severer anemia status and
hematinic deficiencies than AG/RAS patients, to evaluate
whether AG/RAS patients still had anemia and hematinic
deficiencies, to find out what were the common types of
anemia in AGþ/RAS and AG/RAS patients, and to evaluate
whether RAS combined with AG or RAS itself was a signifi-
cant factor that caused anemia and hematinic deficiencies
in AGþ/RAS patients or AG/RAS patients, respectively.Materials and methods
Subjects
In this study, 160 (39 men and 121 women, age range
18e90 years, mean 55.7  15.8 years) AGþ/RAS patients
and 195 (67 men and 128 women, age range 18e90 years,
mean 50.4  15.6 years) AG/RAS patients were collected
in the oral mucosal disease clinic of National Taiwan Uni-
versity Hospital (NTUH). For comparisons, 355 age-
(2 years of each patient’s age) and sex-matched healthy
control subjects (106 men and 249 women, age range
20e89 years, mean age 53.1  14.7 years) were included in
this study. All RAS patients and control subjects were seen
consecutively, diagnosed, and treated in the Department
of Dentistry, NTUH from July 2007 to July 2016. Patients
were diagnosed as having RAS when they had at least one
episode of oral ulcerations on movable oral mucosa per
month since childhood.4 In this study, 160 AGþ/RAS pa-
tients had concomitant partial or complete AG which was
defined as partial or complete absence or flattening of
filiform papillae on the dorsal surface of the tongue,
respectively.5 In contrast, 195 AG/RAS patients did not
have either partial or complete AG. RAS patients with betel
quid chewing habit or autoimmune diseases (such as sys-
temic lupus erythematosus, rheumatoid arthritis, Sjogren’s
syndrome, pemphigus vulgaris, and cicatricial pemphigoid)
were excluded. Moreover, patients with traumatic ulcers or
with aphthous-like ulcers associated with systemic disor-
ders including Behcet’s syndrome, celiac disease, gluten-
sensitive enteropathy, inflammatory bowel diseases,
human immunodeficiency virus infection, and cyclic neu-
tropenia were also excluded.24 In addition, RAS patients
with serum creatinine concentrations indicative of renal
dysfunction (i.e., men, >131 mmol/L; women, >115 mmol/
L), and who reported a history of stroke, heavy alcohol use,
or diseases of the liver, kidney, or coronary arteries were
also excluded.25 Healthy control subjects had either dental
caries, pulpal disease, malocclusion, or missing of teeth
but did not have any oral mucosal or systemic diseases.
None of the RAS patients had taken any prescription
medication for RAS or AG at least 3 months before entering
the study.
The blood samples were drawn from all RAS patients and
healthy control subjects for measurement of complete
blood count, serum iron, vitamin B12, folic acid, homo-
cysteine, and GPCA levels. All RAS patients and healthy
control subjects signed the informed consents before
entering the study. This study was reviewed and approved
by the Institutional Review Board at the NTUH.
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iron, vitamin B12, folic acid and homocysteine
concentrations
The complete blood count and serum iron, vitamin B12,
folic acid, and homocysteine concentrations were deter-
mined by the routine tests performed in the Department of
Laboratory Medicine of NTUH as described previously.4e17
This study defined the Hb and hematinic deficiencies ac-
cording to the World Health Organization (WHO) criteria.
Thus, men with Hb < 13 g/dL and women with Hb < 12 g/dL
were defined as having Hb deficiency or anemia.15,26 Pa-
tients with serum iron level <60 mg/dL,27 vitamin B12 level
<200 pg/mL25 or folic acid level <4 ng/mL28 were defined
as having iron, vitamin B12 or folic acid deficiency,
respectively. Moreover, patients with the serum homocys-
teine level >12.6 mM (which was the mean serum homo-
cysteine level of healthy control subjects plus two standard
deviations) were defined as having abnormally high homo-
cysteine level.
Determination of serum GPCA level
The method of determination of serum GPCA level in our
RAS patients and healthy control subjects have been
described in our previous studies.5e8 The serum GPCA level
was measured to confirm whether RAS patients had perni-
cious anemia.
Statistical analysis
Comparisons of the mean MCV and mean blood levels of Hb,
iron, vitamin B12, folic acid and homocysteine between
AGþ/RAS patients or AG/RAS patients and healthy control
subjects and between AGþ/RAS patients and AG/RAS
patients were performed by Student’s t-test. The differ-
ences in frequency of Hb, iron, vitamin B12 or folic acid
deficiency, or frequency of abnormally high blood homo-
cysteine level between AGþ/RAS patients or AG/RAS pa-
tients and healthy control subjects and between AGþ/RAS
patients and AG/RAS patients were compared by chi-
square test. Comparisons of mean MCV and mean blood
concentrations of Hb, iron, vitamin B12, folic acid and ho-
mocysteine between any two of the three groups of AGþ/
RAS patients or AG/RAS patients with macrocytic, nor-
mocytic or microcytic RBCs were performed by Student’s t-
test. The result was considered to be significant if the P-
value was less than 0.05.
Results
The mean MCV and mean blood concentrations of Hb, iron,
vitamin B12, folic acid, and homocysteine in 160 AGþ/RAS
patients, 195 AG/RAS patients, and 355 healthy control
subjects are shown in Table 1. Because men usually had
higher blood levels of Hb and iron than women, these two
mean levels were calculated separately for men and
women. We found significantly lower mean Hb (for men and
women, both P-values < 0.001), iron (for men, P Z 0.001;
for women, P < 0.001), and vitamin B12 (P Z 0.030) levelsas well as significantly higher mean blood homocysteine
level (P Z 0.003) in AGþ/RAS patients than in healthy
control subjects (Table 1). Moreover, we found a signifi-
cantly lower mean Hb (for men and women, both P-
values < 0.001), and iron level (for women only, PZ 0.039)
and a significantly higher mean blood homocysteine level
(P Z 0.034) in AGþ/RAS patients than in AG/RAS pa-
tients. Furthermore, AG/RAS patients also had signifi-
cantly lower mean Hb (for men and women, both P-
values < 0.001), MCV (P < 0.001), iron (for men, PZ 0.035;
for women, P < 0.001), vitamin B12 (P Z 0.053, marginal
significance), and folic acid levels (PZ 0.002) than healthy
control subjects (Table 1).
We also found significantly greater frequencies of Hb
(P < 0.001), iron (P < 0.001), vitamin B12 (P < 0.001), and
folic acid (P Z 0.014) deficiencies and of high blood ho-
mocysteine level (P < 0.001) in AGþ/RAS patients than in
healthy control subjects (Table 2). There were also signif-
icantly greater frequencies of Hb (P < 0.001) and iron
(PZ 0.001) deficiencies in AGþ/RAS patients than in AG/
RAS patients. Moreover, we also demonstrated significantly
greater frequencies of Hb, iron, vitamin B12, and folic acid
deficiencies (all P-values < 0.001) and of high blood ho-
mocysteine level in AG/RAS patients than in healthy
control subjects (Table 2).
In this study, 69 (43.1%) of 160 AGþ/RAS patients and 38
(19.5%) of 195 AG/RAS patients were diagnosed as having
anemia according to the WHO criteria (Table 3).15,26 The
different anemia types in 69 anemic AGþ/RAS patients and
in 38 anemic AG/RAS patients are described in detail in
Table 3. In this study, PA was diagnosed as having
MCV S 100 fl, vitamin B12 < 200 pg/mL, and serum GPCA
positivity,12e14 iron deficiency anemia as having MCV <80 fl
and iron <60 mg/dL,15,26,27 and thalassemia trait as having
MCV <74 fl, RBC count >5.0  1012/L, and Mentzer index
(MCV/RBC) < 13.18 By these definitions, of 69 anemic AGþ/
RAS patients, 3 had pernicious anemia, 6 had macrocytic
anemia, 30 had normocytic anemia, 23 had iron deficiency
anemia, 5 had thalassemia tract, and 2 had microcytic
anemia but did not have iron deficiency or thalassemia
tract. Moreover, of 38 anemic AG/RAS patients, one had
pernicious anemia, 2 had macrocytic anemia, 26 had nor-
mocytic anemia, 5 had iron deficiency anemia, 3 had thal-
assemia tract, and one had microcytic anemia but did not
iron deficiency or thalassemia tract.
When 160 AGþ/RAS patients were further divided into
three groups: group 1 (10 patients with MCVS 100 fl), group
2 (117 patients with MCV between 80 fl and 99.9 fl), and
group 3 (33 patients with MCV< 80 fl), we found that group 1
patients had significantly lower mean Hb level (for men only,
PZ 0.021), higher MCV (P< 0.001), higher mean serum iron
level (for men only, PZ 0.040), lower mean serum vitamin
B12 (P< 0.001), highermean folic acid level (PZ 0.003), and
higher mean serum homocysteine level (P < 0.001) than
group 2 patients (Table 4). Moreover, group 3 patients had
significantly lower mean Hb level (for women only,
P < 0.001), lower MCV (P < 0.001), and lower mean serum
iron level (for women only, P < 0.001) than group 2 patients
(Table 4). In addition, group 1 patients had higher mean Hb
level (for women only, PZ 0.055, marginal significance) and
significantly higher MCV (P < 0.001), lower mean serum
vitamin B12 level (P < 0.001), higher mean serum folic acid
Table 1 Comparisons of the mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin
B12, folic acid and homocysteine between any two of the three groups of 160 atrophic glossitis-positive recurrent aphthous
stomatitis (AGþ/RAS) patients, 195 AG-negative RAS (AG/RAS) patients, and 355 healthy control subjects.
Group Hb (g/dL) MCV (fl) Iron (mg/dL) Vitamin B12
(pg/mL)
Folic acid
(ng/mL)
Homocysteine
(mM)Men Women Men Women
AGþ/RAS patients
(n Z 160)
12.9  1.8
(n Z 39)
12.4  1.5
(n Z 121)
87.0  9.9 83.6  43.4
(n Z 39)
76.7  35.5
(n Z 121)
620.3  290.1 13.7  6.9 10.6  12.1
P-valuea <0.001 <0.001 <0.001 0.001 <0.001 0.030 0.399 0.003
P-valueb <0.001 <0.001 0.156 0.150 0.039 0.724 0.098 0.034
AG/RAS patients
(n Z 195)
14.6  1.3
(n Z 67)
13.0  1.2
(n Z 128)
88.3  7.3 94.1  30.8
(n Z 67)
85.5  31.4
(n Z 128)
630.7  263.7 12.5  6.7 8.5  6.0
P-valuea <0.001 <0.001 <0.001 0.035 <0.001 0.053 0.002 0.775
Healthy control
subjects (n Z 355)
15.2  0.7
(n Z 106)
13.6  0.7
(n Z 249)
90.7  3.7 103.7  27.6
(n Z 106)
99.0  28.3
(n Z 249)
673.7  240.8 14.2  5.9 8.6  2.0
a Comparisons of parameters between 160 AGþ/RAS patients or 195 AG/RAS patients and 355 healthy control subjects.
b Comparisons of parameters between 160 AGþ/RAS patients and 195 AG/RAS patients.
Table 2 Comparisons of frequencies of hemoglobin (Hb), iron, vitamin B12, and folic acid deficiencies and frequency of
abnormally high blood homocysteine level between any two of the three groups of 160 atrophic glossitis-positive recurrent
aphthous stomatitis (AGþ/RAS) patients, 195 AG-negative RAS (AG/RAS) patients, and 355 healthy control subjects.
Hb deficiency
(Men < 13 g/dL,
Women < 12 g/dL)
Iron deficiency
(<60 mg/dL)
Vitamin B12
deficiency
(<200 pg/mL)
Folic acid
deficiency
(<4 ng/mL)
High homocysteine
level (>12.6 mM)
AGþ/RAS patients (n Z 160) 69 (43.1%) 57 (35.6%) 19 (11.9%) 4 (2.5%) 24 (15.0%)
P-valuea <0.001 <0.001 <0.001 0.014 <0.001
P-valueb <0.001 0.001 0.129 0.592 0.065
AG/RAS patients (n Z 195) 38 (19.5%) 39 (20.0%) 13 (6.7%) 8 (4.1%) 16 (8.2%)
P-valuea <0.001 <0.001 <0.001 <0.001 0.001
Healthy control subjects (n Z 355) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 7 (2.0%)
a Comparisons of parameters between 160 AGþ/RAS patients or 195 AG/RAS patients and 355 healthy control subjects.
b Comparisons of parameters between 160 AGþ/RAS patients and 195 AG/RAS patients.
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(P < 0.001) than group 3 patients (Table 4).
We also divided 195 AG/RAS patients into three groups:
group 1 (3 patients with MCV S 100 fl), group 2 (174 pa-
tients with MCV between 80 fl and 99.9 fl), and group 3 (18
patients with MCV < 80 fl). Because there was only one
male patient in group 1, the Hb and iron data were not
compared between group 1 and group 2 or group 3 male
patients. We found that group 1 patients had significantly
lower mean Hb level (for women only, P Z 0.003), higher
MCV (P < 0.001), higher mean serum iron level (for women
only, P Z 0.024), higher mean serum folic acid level
(P Z 0.056, marginal significance), and higher mean serum
homocysteine level (P < 0.001) than group 2 patients (Table
5). Moreover, group 3 patients had significantly lower mean
Hb level (for men, PZ 0.009; for women, P < 0.001), lower
MCV (P < 0.001), lower mean serum iron level (for women
only, P Z 0.022), and lower mean serum folic acid level
(P Z 0.014) than group 2 patients (Table 5). In addition,
group 1 patients had significantly higher MCV (P < 0.001),
higher mean serum iron level (for women only, P Z 0.059,
marginal significance), higher mean serum folic acid level
(P < 0.001), and higher mean serum homocysteine level
(P Z 0.005) than group 3 patients (Table 5).Discussion
Our previous study demonstrated that 273 RAS patients
have significantly greater frequencies of Hb, serum iron,
vitamin B12, and folic acid deficiencies and of high serum
homocysteine level than 273 age/sex-matched healthy
control subjects.4 However, when the 273 RAS patients are
further divided into 32 major-typed RAS and 241 minor-
typed RAS patients, there are no significant differences in
the frequencies of Hb, serum iron, vitamin B12, and folic
acid deficiencies and of high serum homocysteine level
between the major-typed RAS and minor-typed RAS pa-
tients.4 This study also found that both AGþ/RAS and AG/
RAS patients had significantly greater frequencies of Hb,
serum iron, vitamin B12, and folic acid deficiencies and of
high serum homocysteine level than healthy control sub-
jects. Moreover, AGþ/RAS had significantly greater fre-
quencies of Hb and serum iron deficiencies than AG/RAS
patients. These findings indicate that a significant per-
centage of either AGþ/RAS or AG/RAS patients do have
anemia and hematinic deficiencies and AGþ/RAS patients
do have severer anemia status and iron deficiency than
AG/RAS patients. The findings from our two RAS studies
also suggest that both diseases of AG and RAS play
Table 3 Anemia types of 69 of 160 atrophic glossitis-positive recurrent aphthous stomatitis (AGþ/RAS) patients and 38 of 195
AG-negative RAS (AG/RAS) patients.
Anemia type Patient number (%)
Patient
number (%)
MCV Vitamin B12 deficiency
(<200 g/mL)
Iron deficiency
(<60 mg/dL)
Folic acid deficiency
(<4 ng/mL)
AGD/RAS patients (n [ 160)
Pernicious anemia 3 (4.3) S100 fl 3 (100.0) 0 (0.0) 0 (0.0)
Macrocytic anemia 6 (8.7) S100 fl 6 (100.0) 1 (16.7) 0 (0.0)
Normocytic anemia 30 (43.5) 80e99.9 fl 2 (6.7) 17 (56.7) 1 (3.3)
Iron deficiency anemia 23 (33.3) <80 fl 2 (8.7) 23 (100.0) 3 (13.0)
Thalassemia trait 5 (7.2) <74 fl 0 (0.0) 0 (0.0) 0 (0.0)
Microcytic anemia 2 (2.9) <80 fl 1 (50.0) 0 (0.0) 0 (0.0)
Total 69 (100.0) 14 (20.3) 41 (59.4) 4 (5.8)
AGL/RAS patients (n [ 195)
Pernicious anemia 1 (2.6) S100 fl 1 (100.0) 0 (0.0) 0 (0.0)
Macrocytic anemia 2 (5.3) S100 fl 1 (50.0) 0 (0.0) 0 (0.0)
Normocytic anemia 26 (68.4) 80e99.9 fl 3 (11.5) 13 (50.0) 2 (7.7)
Iron deficiency anemia 5 (13.2) <80 fl 1 (20.0) 5 (100.0) 0 (0.0)
Thalassemia trait 3 (7.9) <74 fl 0 (0.0) 0 (0.0) 0 (0.0)
Microcytic anemia 1 (2.6) <80 fl 0 (0.0) 0 (0.0) 1 (100.0)
Total 38 (100.0) 6 (15.8) 18 (47.4) 3 (7.9)
Table 4 The mean corpuscular volume (MCV), mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic acid,
and homocysteine in 160 atrophic glossitis-positive recurrent aphthous stomatitis (AGþ/RAS) patients including 10 with
MCV S 100 fl (group 1), 117 with MCV between 80 fl and 99.9 fl (group 2), and 33 with MCV < 80 fl (group 3).
AGþ/RAS patients (n Z 160)
Group 1
MCV S 100 fl
(n Z 10)
P-value*
(Group 1 vs. 2)
Group 2
MCV 80-99.9 fl
(n Z 117)
P-value*
(Group 2 vs. 3)
Group 3
MCV < 80 fl
(n Z 33)
P-value*
(Group 1 vs. 3)
Mean  SD Mean  SD Mean  SD
Hb (g/dL)
Men 11.6  0.8
(n Z 7)
0.021 13.4  1.9
(n Z 26)
0.061 11.8  1.3
(n Z 6)
0.740
Women 12.0  0.4
(n Z 3)
0.200 12.9  1.2
(n Z 91)
<0.001 10.7  1.1
(n Z 27)
0.055
MCV (fl) 107.5  7.2 <0.001 89.4  3.9 <0.001 72.2  6.1 <0.001
Iron (mg/dL)
Men 116.4  64.0
(n Z 7)
0.040 78.9  33.2
(n Z 26)
0.405 65.5  43.1
(n Z 6)
0.127
Women 62.0  12.1
(n Z 3)
0.200 85.5  31.3
(n Z 91)
<0.001 48.6  35.9
(n Z 27)
0.531
Vitamin B12
(pg/mL)
156.9  14.8 <0.001 660.5  265.6 0.433 618.2  299.0 <0.001
Folic acid
(ng/mL)
20.3  5.5 0.003 13.6  6.8 0.232 12.0  6.6 <0.001
Homocysteine
(mM)
40.2  32.0 <0.001 8.5  4.3 0.472 9.3  8.9 <0.001
* Comparisons of MCV, mean blood concentrations of Hb, iron, vitamin B12, folic acid and homocysteine between groups 1 and 2,
between groups 2 and 3, and between groups 1 and 3 by Student’s t-test.
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ficiencies (especially iron deficiency) in AGþ/RAS patients,
and RAS itself does play an important role in causing anemia
and hematinic deficiencies in AG/RAS patients.
It is interesting to understand the cause-and-effect
relation between anemia or hematinic deficiencies andRAS. Our previous RAS study and this study showed that Hb,
serum iron, vitamin B12, and folic acid deficiencies can be
detected in 20e43%, 19e36%, 4e12%, and 2e6% of RAS
patients, respectively, depending on different subtypes of
RAS patients.4 In addition, a high homocysteine level was
found in 7e15% of different subtypes of RAS patients.4 Our
Table 5 The mean corpuscular volume (MCV), mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic acid,
and homocysteine in 195 atrophic glossitis-negative recurrent aphthous stomatitis (AG/RAS) patients including 3 with
MCV S 100 fl (group 1), 174 with MCV between 80 fl and 99.9 fl (group 2), and 18 with MCV < 80 fl (group 3).
AG/RAS patients (n Z 195)
Group 1
MCV S 100 fl
(n Z 3)
P-value*
(Group 1 vs. 2)
Group 2
MCV 80e99.9 fl
(n Z 174)
P-value*
(Group 2 vs. 3)
Group 3
MCV < 80 fl
(n Z 18)
P-value*
(Group 1 vs. 3)
Mean  SD Mean  SD Mean  SD
Hb (g/dL)
Men 11.7 (n Z 1) ND 14.8  1.2 (n Z 62) 0.009 13.1  1.6 (n Z 4) ND
Women 10.8  0.8
(n Z 2)
0.003 13.2  1.1 (n Z 112) <0.001 11.9  1.1 (n Z 14) 0.200
MCV (fl) 107.0  1.3 <0.001 89.8  3.9 <0.001 70.7  6.9 <0.001
Iron (mg/dL)
Men 77 (n Z 1) ND 95.6  31.1 (n Z 62) 0.211 75.5  25.7 (n Z 4) ND
Women 134.0  60.8
(n Z 2)
0.024 87.0  28.4 (n Z 112) 0.022 67.3  41.3 (n Z 14) 0.059
Vitamin B12
(pg/mL)
416.7  424.4 0.140 643.2  260.1 0.131 545.8  250.3 0.459
Folic acid
(ng/mL)
20.3  6.4 0.056 12.8  6.7 0.014 8.8  4.5 <0.001
Homocysteine
(mM)
28.2  28.5 <0.001 8.2  4.8 0.797 8.5  3.5 0.005
ND Z not done.
* Comparisons of MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid and homocysteine between groups 1 and 2,
between groups 2 and 3, and between groups 1 and 3 by Student’s t-test.
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B1, B2, B6 and B12, folate, iron, ferritin and Hb in a portion
of RAS patients.4 Iron deficiency causes microcytic ane-
mia27 and deficiencies of vitamin B12 and folic acid lead to
macrocytic anemia.25,29 RAS patients with anemia and
lower Hb levels have reduced capacity of the blood to carry
oxygen to oral mucosa, finally resulting in atrophy of oral
mucosa. In addition, iron is essential to the normal func-
tioning of oral epithelial cells30 and both vitamin B12 and
folic acid play important roles in DNA synthesis and cell
division.25,29 Oral epithelial cells have a high turnover rate.
Therefore, deficiencies of iron, vitamin B12 and folic acid
may result in oral epithelial atrophy. Atrophic oral epithe-
lium in hematinic-deficient patients may explain why some
patients with deficiencies of hematinics are prone to have
RAS. Furthermore, high blood homocysteine level may
result in an elevated frequency of thrombosis in the feeding
arterioles that supply the oral epithelial cells.31e35 This in
turn leads to a breakdown of oral epithelium and finally
produces an oral ulceration. Moreover, replacement ther-
apy with hematinics for RAS patients with deficiencies of
corresponding hematinics can result in a significant clinical
improvement or at least a reduction in frequency and
severity of their oral aphthous ulcers.36e39 Taken these
together, anemia, hematinic deficiencies, and high blood
homocysteine levels can decrease oral epithelial barrier
and thus increase the frequency of RAS occurrence. More-
over, Hb and hematinic deficiencies and high blood homo-
cysteine level may be the causes of RAS.
We further explain why RAS alone or RAS combined with
AG may be the important factors causing anemia andhematinic deficiencies in RAS patients with or without AG.
The results of a previous diet history questionnaire study
indicate a significantly lower daily intake of vitamin B12
and folate in minor-typed RAS patients than in control
subjects.40 By definition, the major-typed RAS patients
often have severer and larger recurrent oral ulcerations
than minor-typed RAS patients.4 These severer ulcerative
lesions may cause burning sensation and pain of the lesional
oral mucosae when the patients eat salty and spicy food
stuffs. The eating difficulty may result in reduced food
intake that in turn leads to anemia and hematinic de-
ficiencies in a certain percentage of our RAS patients.
Regarding the AG, our previous study showed burning
sensation of the tongue, dry mouth, numbness of oral mu-
cosa, and dysfunction of taste in 100%, 79%, 57.4%, and
27.8% of 176 AG patients, respectively.5 Burning sensation
of the tongue, dry mouth, numbness of oral mucosa, and
dysfunction of taste all may interfere with the eating and
swallowing function of AG patients. This can further explain
why AG patients do have anemia and hematinic de-
ficiencies. Indeed, Hb, iron, vitamin B12, and folic acid
deficiencies and high blood homocysteine level can be
found in 22.2%, 26.7%, 7.4%, 1.7% and 21.6% of our 176 AG
patients, respectively.4 Furthermore, supplement treat-
ments with vitamins BC capsules plus corresponding defi-
cient hematinics (vitamin B12, folic acid or iron) or with
vitamin BC capsules alone can not only reduce the high
serum homocysteine levels to significantly lower levels but
also eliminate oral symptoms and signs to a normal oral
condition in AG patients.19 The successful clinical outcomes
for AG patients treated with deficient multiple vitamin and
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and hematinic deficiencies are the possible causes of AG.19
Moreover, the RAS- and AG-induced reduction of food stuff
intake can explain why RAS combined with AG may be the
causes of anemia and hematinic deficiencies in AGþ/RAS
patients, and RAS itself may be an important factor causing
anemia and hematinic deficiencies in AG/RAS patients.
In this study, 69 (43.1%) of the 160 AGþ/RAS patients
and 38 (19.5%) of 195 AG/RAS patients had anemia.15,26
Six types of anemia including pernicious, macrocytic, nor-
mocytic, iron deficiency, or microcytic anemia and thalas-
semia trait were detected in RAS patients. We also found
that 4 of 4 pernicious anemia patients and 7 of 8 macrocytic
anemia patients (one patient had concomitant iron defi-
ciency) had vitamin B12 but not folic acid deficiency, sug-
gesting that these two types of anemia are predominantly
due to vitamin B12 deficiency. Of 56 normocytic anemia
patients, 30 (53.6%) had iron deficiency, 5 (8.9%) had
vitamin B12 deficiency, and 3 (5.4%) had folic acid defi-
ciency, indicating that normocytic anemia in our RAS pa-
tients are predominantly due to iron deficiency and
secondarily due to vitamin B12 and folic acid deficiencies.
In our 28 iron deficiency anemia patients, 3 had concomi-
tant vitamin B12 deficiency and another 3 had folic acid
deficiency. None of our 8 thalassemia trait patients had
vitamin B12, iron or folic acid deficiency. The three
microcytic anemia patients did not have iron deficiency,
but one of them had vitamin B12 deficiency and another
one had folic acid deficiency.
Of the 160 AGþ/RAS patients, 10 (6.3%, group 1 pa-
tients) produced macrocytic RBCs, 117 (73.1%, group 2
patients) normocytic RBCs, and 33 (20.6%, group 3 patients)
microcytic RBCs. Compared to group 2 patients, both
groups 1 and 3 patients had relatively severe anemia, group
3 patients tended to have relatively low serum iron level,
group 1 patients usually had low serum vitamin B12 level
and significantly high blood homocysteine level, and group
3 patients usually had no vitamin B12 and folic acid de-
ficiencies as well as no abnormally high blood homocysteine
level. A similar tendency was also observed in 195 AG/RAS
patients including 3 macrocytosis (group 1), 174 nom-
ocytosis (group 2), and 18 microcytosis (group 3) AG/RAS
patients.
We conclude that a significant percentage of either
AGþ/RAS or AG/RAS patients do have anemia and he-
matinic deficiencies and AGþ/RAS patients do have severer
anemia status and iron deficiency than AG/RAS patients.
Both diseases of AG and RAS play significant roles in causing
anemia and hematinic deficiencies (especially iron defi-
ciency) in AGþ/RAS patients, and RAS itself does play an
important role in causing anemia and hematinic de-
ficiencies in AG/RAS patients. Normocytic anemia and
iron deficiency anemia are two common types of anemia in
RAS patients including AGþ/RAS and AG/RAS patients.
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